Table 2.
Performance in rule-out using biomarkers and ECG.
| Rule-Out Observations: | |||
|---|---|---|---|
| All (n = 1220) |
Non-AMI (n = 975) |
AMI (n = 245) |
|
| hs-TnI 0 h ≤ 3 ng/L AND low risk ECG | 248 (20.7%) |
248 (25.9%) |
0 (0%) |
| hs-TnI 0 h ≤ 3 ng/L AND low risk ECG AND suPAR 0 h < 3.7 ng/mL | 195 (16.2%) |
195 (20.4%) |
0 (0%) |
| hs-TnI 0 h ≤ 6 ng/L AND hs-TnI 1 h ≤ 6 ng/L | 454 (38.1%) |
450 (47.4%) |
4 (1.6%) |
| hs-TnI 0 h ≤ 6 ng/L AND hs-TnI 1 h ≤ 6 ng/L AND suPAR 0 h < 3.7 ng/mL | 327 (27.4%) |
325 (34.2%) |
2 (0.8%) |
| suPAR 0 h < 3.7 ng/mL | 687 (56.3%) |
571 (58.6%) |
116 (47.3%) |
ECG = electrocardiogram, AMI = acute myocardial infarction, hs-TnI = high-sensitivity troponin I, suPAR = soluble urokinase-type plasminogen activator receptor.